Search results
mRNA Technology Promises To Make A Long-Time Coming Turning Point In Cancer Treatment
Benzinga via Yahoo Singapore Finance· 49 minutes agoThe beauty of mRNA technology is that it opens the door to a more personalized and effective...
Tesla, Archer Aviation rise; Eli Lilly falls, Tuesday, 7/2/2024
Associated Press via Yahoo Singapore Finance· 2 hours agoArcher Aviation Inc. (ACHR), up 24 cents to $3.66. The maker of electric vertical take-off and landing aircraft received a $55 million investment from Stellantis. Moderna ...
CHMP Endorses Moderna's (MRNA) mRNA-based RSV Vaccine
Zacks via Yahoo Singapore Finance· 1 day agoThe CDC also clarified that it is not recommending RSV vaccines on an annual basis, which is usually...
Pfizer (PFE), BioNTech's Updated COVID-19 Jab Gets CHMP Nod
Zacks via Yahoo Singapore Finance· 4 days agoPfizer (PFE) and BioNTech's Omicron JN.1-adapted COVID-19 vaccine gets the Committee for Medicinal...
Midday movers: Nike and Accolade fall; Humana and Infinera rise
Investing.com via Yahoo Singapore Finance· 4 days agoThe stock was also downgraded to 'neutral' from 'buy' by analysts at Rosenblatt. Moderna (NASDAQ:MRNA) (MRNA) stock fell 1% despite news ...
Vertex (VRTX) Rises 16.5% YTD: Time to Bet On the Stock?
Zacks via Yahoo Singapore Finance· 5 days agoAdditionally, Vertex is developing an mRNA therapeutic, VX-522, in partnership with Moderna MRNA for...
CDC Advisor Panel Recommends RSV Shots In US For People Above 75 Years, Analyst Says Decision...
Benzinga via Yahoo Singapore Finance· 5 days agoOn Wednesday, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on...
GSK shares slide after US health agency narrows scope of RSV shots
Reuters via Yahoo Singapore Finance· 5 days ago(Reuters) -GSK shares fell as much as 7% on Thursday, a day after a U.S. public health agency...
Why Is Moderna Stock Trading Lower On Wednesday?
Benzinga via Yahoo Singapore Finance· 6 days agoIn the presentation slides to the U.S. agency, Moderna Inc (NASDAQ:MRNA) shared safety set data, with a cut-off date of March 8, 2024, based on the...
Moderna shares decline, RSV vaccine efficacy lags behind competitors
Investing.com via Yahoo Singapore Finance· 6 days agoInvesting.com - Moderna Inc (NASDAQ:MRNA) experienced an 11% drop on Wednesday after the company disclosed that its respiratory syncytial virus (RSV) vaccine, mResvia, exhibited ...